Global Nocturia Industry Trends: Where the Market Is Headed by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The Nocturia Market Size Likely To Evolve From 2025 Through 2034?

The nocturia market has experienced significant expansion in recent years. It is anticipated to increase from $2.87 billion in 2024 to $3.1 billion in 2025, achieving a compound annual growth rate (CAGR) of 8.0%. This market’s historical growth has been driven by factors such as the increasing prevalence of cardiovascular diseases, a rise in the incidence of insomnia, the growing aging population, enhanced awareness of nocturia and related conditions, and an increase in comorbidities.

The nocturia market is poised for substantial growth over the next few years, with projections indicating an expansion to $4.2 billion by 2029, achieving a compound annual growth rate (CAGR) of 7.8%. This anticipated growth is primarily fueled by an increasing prevalence of bladder obstruction disorders and urinary tract inflammation, a rising incidence of excessive nighttime urination (nocturia) stemming from various risk factors, elevated fluid intake contributing to the condition, greater awareness of nocturia’s ties to sleep disorders and kidney health, and an expanding aging population. Furthermore, significant trends expected during this period include advancements in diagnostic methodologies, the development of new pharmaceutical treatments, heightened research and investment in nocturia therapies, progress in both surgical and non-surgical treatment approaches, and the increasing adoption of personalized medicine.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21232&type=smp

What Are The Drivers Pushing New Developments In The Nocturia Market?

The increasing incidence of cardiovascular diseases is anticipated to fuel the expansion of the nocturia market moving forward. Cardiovascular diseases, or CVDs, are a collection of ailments that impact the heart and blood vessels, including conditions such as heart disease, stroke, and hypertension. The widespread occurrence of these diseases can be attributed to elements like an aging global population, sedentary routines, unhealthy dietary habits, smoking, excessive alcohol consumption, obesity, elevated blood pressure, high cholesterol, diabetes, and genetic predisposition. Patients affected by cardiovascular diseases frequently experience nocturia as an associated symptom, which drives up the need for diagnostic tools and treatment solutions. As cardiovascular conditions continue to increase worldwide due to demographic aging and poor lifestyle choices, the requirement for effective nocturia management will also grow. For example, in May 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported that heart disease in the US was responsible for 702,880 fatalities in 2022, constituting 20% of all deaths in the United States. Annually, approximately 805,000 individuals experience a heart attack, with 605,000 representing first-time cases and 200,000 occurring in those with a prior history. Thus, the rising prevalence of cardiovascular diseases is a key factor boosting the growth of the nocturia market.

What Are The Primary Types Of Segments Analyzed In The Nocturia Market?

The nocturiamarket covered in this report is segmented –

1) By Drug: Anticholinergic Drugs; Desmopressin; Antibiotics; Antispasmodic; Other Drugs

2) By Indication: Mixed Nocturia; Low Nocturnal Bladder Capacity; Nocturnal Polyuria; Global Polyuria

3) By Causes: Urological Infection; Tumor Of The bladder; Diuretic Medications; Regular Alcohol Or coffee; Liver infection; Diabetes; Pregnancy; Other Causes

4) By End User: Hospitals; Home Care; Clinics

Subsegments:

1) By Anticholinergic Drugs: Oxybutynin; Tolterodine; Solifenacin; Darifenacin; Fesoterodine

2) By Desmopressin: Intranasal Desmopressin; Oral Desmopressin

3) By Antibiotics: Nitrofurantoin; Trimethoprim; Fosfomycin; Other Antibiotics

4) By Antispasmodic: Hyoscine Butylbromide; Flavoxate; Other Antispasmodics

5) By Other Drugs: Alpha-blockers; Beta-3 Agonists; Diuretics; Other Pharmacological Treatments

What Are The Latest Industry Trends Transforming The Nocturia Market?

Leading companies in the nocturia market are concentrating on creating innovative products, such as orally disintegrating tablets, to improve patient convenience and adherence. Orally disintegrating tablets (ODTs) are solid drug forms that rapidly dissolve in the mouth without the need for water, making them perfect for patients who struggle with swallowing. For example, in July 2024, Adalvo Limited, a Malta-based pharmaceutical company, introduced Desmopressin ODT in Europe. This launch targets conditions leading to excessive fluid loss from the body, including central cranial diabetes insipidus. This synthetic version of the vasopressin tablet addresses diabetes insipidus, extreme thirst and urination, and bedwetting by mimicking the body’s natural hormone and reducing the amount of water expelled in urine. Additionally, it is utilized to manage bleeding in mild to moderate hemophilia A and von Willebrand disease by encouraging the release of blood clotting factors.

Who Are The Prominent Global Companies Shaping The Nocturia Market?

Major companies operating in the nocturia market are Pfizer Inc, Merck & Co. Inc, AbbVie Inc, Sanofi S.A, GlaxoSmithKline plc, Viatris Inc, Boehringer Ingelheim International GmbH, Otsuka Pharmaceutical Co. Ltd, Astellas Pharma Inc, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd, Ferring Pharmaceuticals A/S, Avadel Pharmaceuticals plc, UroGen Pharma Ltd, Sanwa Kagaku Co. Ltd., Urovant Sciences Inc, Serenity Pharmaceuticals LLC, Vantia Therapeutics Inc, AA Pharma Inc, Wellesley Pharmaceuticals Inc

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/nocturia-global-market-report

Which Region Currently Holds The Largest Share Of The Nocturia Market?

North America was the largest region in the nocturia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nocturia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Nocturia Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21232&type=smp

Browse Through More Reports Similar to the Global Nocturia Market 2025, By The Business Research Company

Sleep Apnea Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/sleep-apnea-devices-global-market-report

Sleep Tech Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/sleep-tech-devices-global-market-report

Sleep Testing Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/sleep-testing-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795